PF4 and deep vein thrombosis: LMWHs is an important tool in DVT management, offering advantages over UFH, considering the reduced risk for HIT [6], a prothrombotic adverse drug reaction caused by platelet-activating antibodies that recognize the complex of platelet factor 4 (PF4) bound to heparin [7].